|
- 2018
An Evidence-Based Review of Statin Use in Patients With Nonalcoholic Fatty Liver DiseaseKeywords: Nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, HMG-CoA reductase inhibitors, statins, safety Abstract: Nonalcoholic fatty liver disease (NAFLD) is a common complication in patients with metabolic syndrome. The role of statin therapy specifically for the treatment of NAFLD remains unknown. The aim of this review is to discuss outcomes of recent articles analyzing statin therapy in patients with NAFLD
|